976 related articles for article (PubMed ID: 18310361)
1. Prevalence and instability of fragile X alleles: implications for offering fragile X prenatal diagnosis.
Cronister A; Teicher J; Rohlfs EM; Donnenfeld A; Hallam S
Obstet Gynecol; 2008 Mar; 111(3):596-601. PubMed ID: 18310361
[TBL] [Abstract][Full Text] [Related]
2. Fragile X analysis of 1112 prenatal samples from 1991 to 2010.
Nolin SL; Glicksman A; Ding X; Ersalesi N; Brown WT; Sherman SL; Dobkin C
Prenat Diagn; 2011 Oct; 31(10):925-31. PubMed ID: 21717484
[TBL] [Abstract][Full Text] [Related]
3. Screening and instability of FMR1 alleles in a prospective sample of 24,449 mother-newborn pairs from the general population.
Lévesque S; Dombrowski C; Morel ML; Rehel R; Côté JS; Bussières J; Morgan K; Rousseau F
Clin Genet; 2009 Dec; 76(6):511-23. PubMed ID: 19863547
[TBL] [Abstract][Full Text] [Related]
4. Prenatal carrier testing for fragile X: counseling issues and challenges.
Musci TJ; Moyer K
Obstet Gynecol Clin North Am; 2010 Mar; 37(1):61-70, Table of Contents. PubMed ID: 20494258
[TBL] [Abstract][Full Text] [Related]
5. Analysis of CGG variation through 642 meioses in Fragile X families.
Rifé M; Badenas C; Quintó L; Puigoriol E; Tazón B; Rodriguez-Revenga L; Jiménez L; Sánchez A; Milà M
Mol Hum Reprod; 2004 Oct; 10(10):773-6. PubMed ID: 15322225
[TBL] [Abstract][Full Text] [Related]
6. Premature ovarian failure and fragile X female premutation carriers: no evidence for a skewed X-chromosome inactivation pattern.
Rodriguez-Revenga L; Madrigal I; Badenas C; Xunclà M; Jiménez L; Milà M
Menopause; 2009; 16(5):944-9. PubMed ID: 19373114
[TBL] [Abstract][Full Text] [Related]
7. Analysis of the molecular parameters that could predict the risk of manifesting premature ovarian failure in female premutation carriers of fragile X syndrome.
Tejada MI; García-Alegría E; Bilbao A; Martínez-Bouzas C; Beristain E; Poch M; Ramos-Arroyo MA; López B; Fernandez Carvajal I; Ribate MP; Ramos F
Menopause; 2008; 15(5):945-9. PubMed ID: 18427356
[TBL] [Abstract][Full Text] [Related]
8. Molecular screening of fragile X (FRAXA) and FRAXE mental retardation syndromes in the Hellenic population of Greece and Cyprus: incidence, genetic variation, and stability.
Patsalis PC; Sismani C; Hettinger JA; Boumba I; Georgiou I; Stylianidou G; Anastasiadou V; Koukoulli R; Pagoulatos G; Syrrou M
Am J Med Genet; 1999 May; 84(3):184-90. PubMed ID: 10331587
[TBL] [Abstract][Full Text] [Related]
9. Assessment of a clinical checklist in the diagnosis of fragile X syndrome in India.
Guruju MR; Lavanya K; Thelma BK; Sujatha M; OmSai VR; Nagarathna V; Amarjyothi P; Jyothi A; Anandaraj MP
J Clin Neurosci; 2009 Oct; 16(10):1305-10. PubMed ID: 19560928
[TBL] [Abstract][Full Text] [Related]
10. Identification of fragile X pre-mutation carriers in the Chinese obstetric population using a robust FMR1 polymerase chain reaction assay: implications for screening and prenatal diagnosis.
Cheng YK; Lin CS; Kwok YK; Chan YM; Lau TK; Leung TY; Choy KW
Hong Kong Med J; 2017 Apr; 23(2):110-6. PubMed ID: 28253484
[TBL] [Abstract][Full Text] [Related]
11. Expansion mutation frequency and CGG/GCC repeat polymorphism in FMR1 and FMR2 genes in an Indian population.
Sharma D; Gupta M; Thelma BK
Genet Epidemiol; 2001 Jan; 20(1):129-144. PubMed ID: 11119302
[TBL] [Abstract][Full Text] [Related]
12. Reproductive health of adolescent girls who carry the FMR1 premutation: expected phenotype based on current knowledge of fragile x-associated primary ovarian insufficiency.
De Caro JJ; Dominguez C; Sherman SL
Ann N Y Acad Sci; 2008; 1135():99-111. PubMed ID: 18574214
[TBL] [Abstract][Full Text] [Related]
13. Anti-Mullerian hormone indicates early ovarian decline in fragile X mental retardation (FMR1) premutation carriers: a preliminary study.
Rohr J; Allen EG; Charen K; Giles J; He W; Dominguez C; Sherman SL
Hum Reprod; 2008 May; 23(5):1220-5. PubMed ID: 18310677
[TBL] [Abstract][Full Text] [Related]
14. Molecular diagnosis and genetic counseling for fragile X mental retardation.
Pandey UB; Phadke SR; Mittal B
Neurol India; 2004 Mar; 52(1):36-42. PubMed ID: 15069237
[TBL] [Abstract][Full Text] [Related]
15. Genetic variation and intergenerational FMR1 CGG-repeat stability in 100 unrelated three-generation families from the normal population.
Patsalis PC; Sismani C; Stylianou S; Ioannou P; Joseph G; Manoli P; Holden JJ; Hettinger JA
Am J Med Genet; 1999 May; 84(3):217-20. PubMed ID: 10331595
[TBL] [Abstract][Full Text] [Related]
16. The significance of fragile X mental retardation gene 1 CGG repeat sizes in the normal and intermediate range in women with primary ovarian insufficiency.
Voorhuis M; Onland-Moret NC; Janse F; Ploos van Amstel HK; Goverde AJ; Lambalk CB; Laven JS; van der Schouw YT; Broekmans FJ; Fauser BC;
Hum Reprod; 2014 Jul; 29(7):1585-93. PubMed ID: 24812319
[TBL] [Abstract][Full Text] [Related]
17. Fragile X premutation with atypical symptoms at onset.
Cellini E; Forleo P; Ginestroni A; Nacmias B; Tedde A; Bagnoli S; Mascalchi M; Sorbi S; Piacentini S
Arch Neurol; 2006 Aug; 63(8):1135-8. PubMed ID: 16908740
[TBL] [Abstract][Full Text] [Related]
18. Influence of intermediate and uninterrupted FMR1 CGG expansions in premature ovarian failure manifestation.
Bodega B; Bione S; Dalprà L; Toniolo D; Ornaghi F; Vegetti W; Ginelli E; Marozzi A
Hum Reprod; 2006 Apr; 21(4):952-7. PubMed ID: 16361284
[TBL] [Abstract][Full Text] [Related]
19. Fragile-X carrier screening and the prevalence of premutation and full-mutation carriers in Israel.
Toledano-Alhadef H; Basel-Vanagaite L; Magal N; Davidov B; Ehrlich S; Drasinover V; Taub E; Halpern GJ; Ginott N; Shohat M
Am J Hum Genet; 2001 Aug; 69(2):351-60. PubMed ID: 11443541
[TBL] [Abstract][Full Text] [Related]
20. Preimplantation genetic diagnosis for fragile X syndrome: is there increased transmission of abnormal FMR1 alleles among female heterozygotes?
Reches A; Malcov M; Ben-Yosef D; Azem F; Amit A; Yaron Y
Prenat Diagn; 2009 Jan; 29(1):57-61. PubMed ID: 19097038
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
